Year |
Citation |
Score |
2019 |
Bera TK, Liu W, Leshem J, King E, Kozlov S, Pastan I. Generation of a Transgenic BALB/c Mouse Line With Selective Expression of Human Mesothelin in Thyroid Gland: Application in Mesothelin-targeted Immunotherapy. Journal of Immunotherapy (Hagerstown, Md. : 1997). PMID 30933045 DOI: 10.1097/CJI.0000000000000263 |
0.308 |
|
2018 |
Wei J, Bera TK, Liu XF, Zhou Q, Onda M, Ho M, Tai CH, Pastan I. Recombinant immunotoxins with albumin-binding domains have long half-lives and high antitumor activity. Proceedings of the National Academy of Sciences of the United States of America. PMID 29581296 DOI: 10.1073/pnas.1721780115 |
0.331 |
|
2018 |
Müller F, Cunningham T, Stookey S, Tai CH, Burkett S, Jailwala P, Stetler Stevenson M, Cam MC, Wayne AS, Pastan I. 5-Azacytidine prevents relapse and produces long-term complete remissions in leukemia xenografts treated with Moxetumomab pasudotox. Proceedings of the National Academy of Sciences of the United States of America. PMID 29432154 DOI: 10.1073/pnas.1714512115 |
0.308 |
|
2017 |
Liu XF, Zhou Q, Hassan R, Pastan I. Panbinostat decreases cFLIP and enhances killing of cancer cells by immunotoxin LMB-100 by stimulating the extrinsic apoptotic pathway. Oncotarget. 8: 87307-87316. PMID 29152082 DOI: 10.18632/oncotarget.20263 |
0.309 |
|
2017 |
Bera TK, Abe Y, Ise T, Oberle A, Gallardo D, Liu XF, Nagata S, Binder M, Pastan I. Recombinant immunotoxins targeting B-cell maturation antigen are cytotoxic to myeloma cell lines and myeloma cells from patients. Leukemia. PMID 29149102 DOI: 10.1038/leu.2017.315 |
0.308 |
|
2017 |
Mazor R, Kaplan G, Park D, Jang Y, Lee F, Kreitman R, Pastan I. Rational design of low immunogenic anti CD25 recombinant immunotoxin for T cell malignancies by elimination of T cell epitopes in PE38. Cellular Immunology. PMID 28087047 DOI: 10.1016/j.cellimm.2017.01.003 |
0.309 |
|
2016 |
Hassan R, Thomas A, Alewine C, Le DT, Jaffee EM, Pastan I. Mesothelin Immunotherapy for Cancer: Ready for Prime Time? Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 34: 4171-4179. PMID 27863199 DOI: 10.1200/Jco.2016.68.3672 |
0.303 |
|
2016 |
Antignani A, Mathews Griner L, Guha R, Simon N, Pasetto M, Keller J, Huang M, Angelus E, Pastan I, Ferrer M, FitzGerald DJ, Thomas CJ. Chemical Screens Identify Drugs that Enhance or Mitigate Cellular Responses to Antibody-Toxin Fusion Proteins. Plos One. 11: e0161415. PMID 27556570 DOI: 10.1371/Journal.Pone.0161415 |
0.313 |
|
2016 |
Awuah P, Bera TK, Folivi M, Chertov O, Pastan I. Reduced Shedding of Surface Mesothelin Improves Efficacy of Mesothelin Targeting Recombinant Immunotoxins. Molecular Cancer Therapeutics. PMID 27196771 DOI: 10.1158/1535-7163.MCT-15-0863 |
0.312 |
|
2016 |
Mazor R, Onda M, Park D, Addissie S, Xiang L, Zhang J, Hassan R, Pastan I. Dual B- and T-cell de-immunization of recombinant immunotoxin targeting mesothelin with high cytotoxic activity. Oncotarget. PMID 27167198 DOI: 10.18632/oncotarget.9171 |
0.321 |
|
2016 |
Alewine C, Landsman R, Rudloff M, Kolyvas E, Chen J, Pastan I. Abstract B37: Mesothelin-targeted immunotoxin RG7787 (LMB-100) preferentially depletes secreted proteins and short-lived intracellular proteins to augment tumor cell killing by taxanes Cancer Research. 76. DOI: 10.1158/1538-7445.Panca16-B37 |
0.308 |
|
2015 |
Kreitman RJ, Pastan I. Immunoconjugates in the management of hairy cell leukemia. Best Practice & Research. Clinical Haematology. 28: 236-45. PMID 26614902 DOI: 10.1016/j.beha.2015.09.003 |
0.312 |
|
2015 |
Mazor R, Zhang J, Xiang L, Addissie S, Awuah P, Beers R, Hassan R, Pastan I. Recombinant Immunotoxin with T Cell Epitope Mutations that Greatly Reduce Immunogenicity for Treatment of Mesothelin Expressing Tumors. Molecular Cancer Therapeutics. PMID 26443804 DOI: 10.1158/1535-7163.MCT-15-0532 |
0.308 |
|
2015 |
Stahl S, da Silva Mateus Seidl AR, Ducret A, Kux van Geijtenbeek S, Michel S, Racek T, Birzele F, Haas AK, Rueger R, Gerg M, Niederfellner G, Pastan I, Brinkmann U. Loss of diphthamide pre-activates NF-κB and death receptor pathways and renders MCF7 cells hypersensitive to tumor necrosis factor. Proceedings of the National Academy of Sciences of the United States of America. 112: 10732-7. PMID 26261303 DOI: 10.1073/pnas.1512863112 |
0.322 |
|
2015 |
Weldon JE, Skarzynski M, Therres JA, Ostovitz JR, Zhou H, Kreitman RJ, Pastan I. Designing the furin-cleavable linker in recombinant immunotoxins based on Pseudomonas exotoxin A. Bioconjugate Chemistry. 26: 1120-8. PMID 25997032 DOI: 10.1021/Acs.Bioconjchem.5B00190 |
0.316 |
|
2015 |
Zhang YF, Phung Y, Gao W, Kawa S, Hassan R, Pastan I, Ho M. New high affinity monoclonal antibodies recognize non-overlapping epitopes on mesothelin for monitoring and treating mesothelioma. Scientific Reports. 5: 9928. PMID 25996440 DOI: 10.1038/srep09928 |
0.315 |
|
2015 |
Hollevoet K, Mason-Osann E, Müller F, Pastan I. Methylation-associated partial down-regulation of mesothelin causes resistance to anti-mesothelin immunotoxins in a pancreatic cancer cell line. Plos One. 10: e0122462. PMID 25803818 DOI: 10.1371/journal.pone.0122462 |
0.302 |
|
2015 |
Pasetto M, Antignani A, Ormanoglu P, Buehler E, Guha R, Pastan I, Martin SE, FitzGerald DJ. Whole-genome RNAi screen highlights components of the endoplasmic reticulum/Golgi as a source of resistance to immunotoxin-mediated cytotoxicity. Proceedings of the National Academy of Sciences of the United States of America. 112: E1135-42. PMID 25713356 DOI: 10.1073/Pnas.1501958112 |
0.315 |
|
2015 |
Leshem J, Liu X, Bera T, Terabe M, Berzofsky JA, Bossenmaier B, Niederfellner G, Pastan I. Combining anti-CTLA4 with RG7787, an immunotoxin targeting mesothelin, promotes tumor eradication Journal For Immunotherapy of Cancer. 3. DOI: 10.1186/2051-1426-3-S2-P190 |
0.308 |
|
2014 |
Pak Y, Pastan I, Kreitman RJ, Lee B. Effect of antigen shedding on targeted delivery of immunotoxins in solid tumors from a mathematical model. Plos One. 9: e110716. PMID 25343405 DOI: 10.1371/journal.pone.0110716 |
0.303 |
|
2014 |
Wright SE, Rewers-Felkins KA, Quinlin I, Chowdhury NI, Ahmed J, Eldridge PW, Srivastava SK, Pastan I. TGFα-PE38 enhances cytotoxic T-lymphocyte killing of breast cancer cells. Oncology Letters. 7: 2113-2117. PMID 24932299 DOI: 10.3892/ol.2014.1969 |
0.313 |
|
2014 |
Mazor R, Eberle JA, Hu X, Vassall AN, Onda M, Beers R, Lee EC, Kreitman RJ, Lee B, Baker D, King C, Hassan R, Benhar I, Pastan I. Recombinant immunotoxin for cancer treatment with low immunogenicity by identification and silencing of human T-cell epitopes. Proceedings of the National Academy of Sciences of the United States of America. 111: 8571-6. PMID 24799704 DOI: 10.1073/Pnas.1405153111 |
0.58 |
|
2013 |
Hassan R, Miller AC, Sharon E, Thomas A, Reynolds JC, Ling A, Kreitman RJ, Miettinen MM, Steinberg SM, Fowler DH, Pastan I. Major cancer regressions in mesothelioma after treatment with an anti-mesothelin immunotoxin and immune suppression. Science Translational Medicine. 5: 208ra147. PMID 24154601 DOI: 10.1126/scitranslmed.3006941 |
0.309 |
|
2013 |
Huang YH, Terabe M, Pendleton CD, Stewart Khursigara D, Bera TK, Pastan I, Berzofsky JA. Identification and enhancement of HLA-A2.1-restricted CTL epitopes in a new human cancer antigen-POTE. Plos One. 8: e64365. PMID 23750208 DOI: 10.1371/journal.pone.0064365 |
0.301 |
|
2013 |
Choi BD, Pastan I, Bigner DD, Sampson JH. A novel bispecific antibody recruits T cells to eradicate tumors in the "immunologically privileged" central nervous system. Oncoimmunology. 2: e23639. PMID 23734318 DOI: 10.4161/Onci.23639 |
0.3 |
|
2013 |
Wei H, Bera TK, Wayne AS, Xiang L, Colantonio S, Chertov O, Pastan I. A modified form of diphthamide causes immunotoxin resistance in a lymphoma cell line with a deletion of the WDR85 gene. The Journal of Biological Chemistry. 288: 12305-12. PMID 23486472 DOI: 10.1074/jbc.M113.461343 |
0.304 |
|
2013 |
Choi BD, Kuan CT, Cai M, Archer GE, Mitchell DA, Gedeon PC, Sanchez-Perez L, Pastan I, Bigner DD, Sampson JH. Systemic administration of a bispecific antibody targeting EGFRvIII successfully treats intracerebral glioma. Proceedings of the National Academy of Sciences of the United States of America. 110: 270-5. PMID 23248284 DOI: 10.1073/Pnas.1219817110 |
0.32 |
|
2013 |
Weldon JE, Xiang L, Zhang J, Beers R, Walker DA, Onda M, Hassan R, Pastan I. A recombinant immunotoxin against the tumor-associated antigen mesothelin reengineered for high activity, low off-target toxicity, and reduced antigenicity. Molecular Cancer Therapeutics. 12: 48-57. PMID 23136186 DOI: 10.1158/1535-7163.Mct-12-0336 |
0.313 |
|
2013 |
Mazor R, Vassall AN, Eberle JA, Beers R, Hu X, Benhar I, Pastan I. Abstract 4334: Identification and elimination of T-cell epitopes in recombinant immunotoxins used to treat cancer. Cancer Research. 73: 4334-4334. DOI: 10.1158/1538-7445.Am2013-4334 |
0.586 |
|
2012 |
Mazor R, Vassall AN, Eberle JA, Beers R, Weldon JE, Venzon DJ, Tsang KY, Benhar I, Pastan I. Identification and elimination of an immunodominant T-cell epitope in recombinant immunotoxins based on Pseudomonas exotoxin A. Proceedings of the National Academy of Sciences of the United States of America. 109: E3597-603. PMID 23213206 DOI: 10.1073/Pnas.1218138109 |
0.59 |
|
2012 |
Tortorella LL, Pipalia NH, Mukherjee S, Pastan I, Fitzgerald D, Maxfield FR. Efficiency of immunotoxin cytotoxicity is modulated by the intracellular itinerary. Plos One. 7: e47320. PMID 23056628 DOI: 10.1371/Journal.Pone.0047320 |
0.542 |
|
2012 |
Liu W, Onda M, Lee B, Kreitman RJ, Hassan R, Xiang L, Pastan I. Recombinant immunotoxin engineered for low immunogenicity and antigenicity by identifying and silencing human B-cell epitopes. Proceedings of the National Academy of Sciences of the United States of America. 109: 11782-7. PMID 22753489 DOI: 10.1073/pnas.1209292109 |
0.338 |
|
2012 |
Liu XF, Bera TK, Kahue C, Escobar T, Fei Z, Raciti GA, Pastan I. ANKRD26 and its interacting partners TRIO, GPS2, HMMR and DIPA regulate adipogenesis in 3T3-L1 cells. Plos One. 7: e38130. PMID 22666460 DOI: 10.1371/journal.pone.0038130 |
0.302 |
|
2012 |
Pak Y, Zhang Y, Pastan I, Lee B. Antigen shedding may improve efficiencies for delivery of antibody-based anticancer agents in solid tumors. Cancer Research. 72: 3143-52. PMID 22562466 DOI: 10.1158/0008-5472.CAN-11-3925 |
0.302 |
|
2012 |
Baskar S, Wiestner A, Wilson WH, Pastan I, Rader C. Targeting malignant B cells with an immunotoxin against ROR1. Mabs. 4: 349-61. PMID 22531447 DOI: 10.4161/Mabs.19870 |
0.32 |
|
2012 |
Liu W, Onda M, Kim C, Xiang L, Weldon JE, Lee B, Pastan I. A recombinant immunotoxin engineered for increased stability by adding a disulfide bond has decreased immunogenicity. Protein Engineering, Design & Selection : Peds. 25: 1-6. PMID 22101015 DOI: 10.1093/Protein/Gzr053 |
0.304 |
|
2012 |
Liu XF, Xiang L, Zhang Y, Becker KG, Bera TK, Pastan I. CAPC negatively regulates NF-κB activation and suppresses tumor growth and metastasis. Oncogene. 31: 1673-82. PMID 21822313 DOI: 10.1038/onc.2011.355 |
0.309 |
|
2011 |
Kreitman RJ, Pastan I. Antibody fusion proteins: anti-CD22 recombinant immunotoxin moxetumomab pasudotox. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 17: 6398-405. PMID 22003067 DOI: 10.1158/1078-0432.CCR-11-0487 |
0.333 |
|
2011 |
Zhang Y, Chertov O, Zhang J, Hassan R, Pastan I. Cytotoxic activity of immunotoxin SS1P is modulated by TACE-dependent mesothelin shedding. Cancer Research. 71: 5915-22. PMID 21775520 DOI: 10.1158/0008-5472.CAN-11-0466 |
0.307 |
|
2011 |
Fitzgerald DJ, Moskatel E, Ben-Josef G, Traini R, Tendler T, Sharma A, Antignani A, Mussai F, Wayne A, Kreitman RJ, Pastan I. Enhancing immunotoxin cell-killing activity via combination therapy with ABT-737. Leukemia & Lymphoma. 52: 79-81. PMID 21599608 DOI: 10.3109/10428194.2011.569961 |
0.323 |
|
2011 |
Pastan I, Onda M, Weldon J, Fitzgerald D, Kreitman R. Immunotoxins with decreased immunogenicity and improved activity. Leukemia & Lymphoma. 52: 87-90. PMID 21504287 DOI: 10.3109/10428194.2011.573039 |
0.329 |
|
2011 |
Onda M, Beers R, Xiang L, Lee B, Weldon JE, Kreitman RJ, Pastan I. Recombinant immunotoxin against B-cell malignancies with no immunogenicity in mice by removal of B-cell epitopes. Proceedings of the National Academy of Sciences of the United States of America. 108: 5742-7. PMID 21436054 DOI: 10.1073/Pnas.1102746108 |
0.326 |
|
2011 |
Ho M, Feng M, Fisher RJ, Rader C, Pastan I. A novel high-affinity human monoclonal antibody to mesothelin. International Journal of Cancer. Journal International Du Cancer. 128: 2020-30. PMID 20635390 DOI: 10.1002/Ijc.25557 |
0.315 |
|
2011 |
Kreitman RJ, Singh R, Stetler-Stevenson M, Waldmann TA, Pastan I. Regression of Adult T-Cell Leukemia with Anti-CD25 Recombinant Immunotoxin LMB-2 Preceded by Chemotherapy Blood. 118: 2575-2575. DOI: 10.1182/Blood.V118.21.2575.2575 |
0.309 |
|
2010 |
Hansen JK, Weldon JE, Xiang L, Beers R, Onda M, Pastan I. A recombinant immunotoxin targeting CD22 with low immunogenicity, low nonspecific toxicity, and high antitumor activity in mice. Journal of Immunotherapy (Hagerstown, Md. : 1997). 33: 297-304. PMID 20445350 DOI: 10.1097/Cji.0B013E3181Cd1164 |
0.316 |
|
2010 |
Bogner C, Dechow T, Ringshausen I, Wagner M, Oelsner M, Lutzny G, Licht T, Peschel C, Pastan I, Kreitman RJ, Decker T. Immunotoxin BL22 induces apoptosis in mantle cell lymphoma (MCL) cells dependent on Bcl-2 expression. British Journal of Haematology. 148: 99-109. PMID 19821820 DOI: 10.1111/j.1365-2141.2009.07939.x |
0.316 |
|
2010 |
Pastan I, Roth J, Macchia V. Binding of hormone to tissue: the first step in polypeptide hormone action. Proceedings of the National Academy of Sciences of the United States of America. 56: 1802-9. PMID 16591423 DOI: 10.1073/PNAS.56.6.1802 |
0.348 |
|
2009 |
Xiao X, Ho M, Zhu Z, Pastan I, Dimitrov DS. Identification and characterization of fully human anti-CD22 monoclonal antibodies. Mabs. 1: 297-303. PMID 20065646 DOI: 10.4161/mabs.1.3.8113 |
0.31 |
|
2009 |
Liu XF, Bera TK, Liu LJ, Pastan I. A primate-specific POTE-actin fusion protein plays a role in apoptosis. Apoptosis : An International Journal On Programmed Cell Death. 14: 1237-44. PMID 19669888 DOI: 10.1007/s10495-009-0392-0 |
0.317 |
|
2009 |
Ho M, Pastan I. Display and selection of scFv antibodies on HEK-293T cells. Methods in Molecular Biology (Clifton, N.J.). 562: 99-113. PMID 19554290 DOI: 10.1007/978-1-60327-302-2_8 |
0.328 |
|
2009 |
Feng Y, Xiao X, Zhu Z, Streaker E, Ho M, Pastan I, Dimitrov DS. A novel human monoclonal antibody that binds with high affinity to mesothelin-expressing cells and kills them by antibody-dependent cell-mediated cytotoxicity. Molecular Cancer Therapeutics. 8: 1113-8. PMID 19417159 DOI: 10.1158/1535-7163.MCT-08-0945 |
0.323 |
|
2009 |
Ho M, Pastan I. Mammalian cell display for antibody engineering. Methods in Molecular Biology (Clifton, N.J.). 525: 337-52, xiv. PMID 19252852 DOI: 10.1007/978-1-59745-554-1_18 |
0.321 |
|
2009 |
Anaganti S, Hansen JK, Ha D, Hahn Y, Chertov O, Pastan I, Bera TK. Non-AUG translational initiation of a short CAPC transcript generating protein isoform. Biochemical and Biophysical Research Communications. 380: 508-13. PMID 19250639 DOI: 10.1016/J.Bbrc.2009.01.089 |
0.309 |
|
2009 |
Carpenito C, Milone MC, Hassan R, Simonet JC, Lakhal M, Suhoski MM, Varela-Rohena A, Haines KM, Heitjan DF, Albelda SM, Carroll RG, Riley JL, Pastan I, June CH. Control of large, established tumor xenografts with genetically retargeted human T cells containing CD28 and CD137 domains. Proceedings of the National Academy of Sciences of the United States of America. 106: 3360-5. PMID 19211796 DOI: 10.1073/Pnas.0813101106 |
0.313 |
|
2008 |
Laheru DA, Cohen SJ, Phillips M, Armstrong DK, Brahmer J, Jaffee EM, Weil S, Pastan I, Hassan R. A phase I study of MORab-009, a monoclonal antibody against mesothelin, in mesothelioma, pancreatic and ovarian cancer. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 26: 3578. PMID 27949713 DOI: 10.1200/Jco.2008.26.15_Suppl.3578 |
0.319 |
|
2008 |
Das S, Hahn Y, Walker DA, Nagata S, Willingham MC, Peehl DM, Bera TK, Lee B, Pastan I. Topology of NGEP, a prostate-specific cell:cell junction protein widely expressed in many cancers of different grade level. Cancer Research. 68: 6306-12. PMID 18676855 DOI: 10.1158/0008-5472.CAN-08-0870 |
0.319 |
|
2008 |
Bera TK, Saint Fleur A, Ha D, Yamada M, Lee Y, Lee B, Hahn Y, Kaufman DS, Pera M, Pastan I. Selective POTE paralogs on chromosome 2 are expressed in human embryonic stem cells. Stem Cells and Development. 17: 325-32. PMID 18447647 DOI: 10.1089/Scd.2007.0079 |
0.315 |
|
2008 |
Epel M, Carmi I, Soueid-Baumgarten S, Oh SK, Bera T, Pastan I, Berzofsky J, Reiter Y. Targeting TARP, a novel breast and prostate tumor-associated antigen, with T cell receptor-like human recombinant antibodies. European Journal of Immunology. 38: 1706-20. PMID 18446790 DOI: 10.1002/eji.200737524 |
0.325 |
|
2008 |
Levitin F, Weiss M, Hahn Y, Stern O, Papke RL, Matusik R, Nandana SR, Ziv R, Pichinuk E, Salame S, Bera T, Vincent J, Lee B, Pastan I, Wreschner DH. PATE gene clusters code for multiple, secreted TFP/Ly-6/uPAR proteins that are expressed in reproductive and neuron-rich tissues and possess neuromodulatory activity. The Journal of Biological Chemistry. 283: 16928-39. PMID 18387948 DOI: 10.1074/Jbc.M801454200 |
0.3 |
|
2008 |
Ise T, Das S, Nagata S, Maeda H, Lee Y, Onda M, Anver MR, Bera TK, Pastan I. Expression of POTE protein in human testis detected by novel monoclonal antibodies. Biochemical and Biophysical Research Communications. 365: 603-8. PMID 17996727 DOI: 10.1016/j.bbrc.2007.10.195 |
0.306 |
|
2007 |
Yokokawa J, Bera TK, Palena C, Cereda V, Remondo C, Gulley JL, Arlen PM, Pastan I, Schlom J, Tsang KY. Identification of cytotoxic T-lymphocyte epitope(s) and its agonist epitope(s) of a novel target for vaccine therapy (PAGE4). International Journal of Cancer. Journal International Du Cancer. 121: 595-605. PMID 17397028 DOI: 10.1002/ijc.22698 |
0.302 |
|
2007 |
Das S, Hahn Y, Nagata S, Willingham MC, Bera TK, Lee B, Pastan I. NGEP, a prostate-specific plasma membrane protein that promotes the association of LNCaP cells. Cancer Research. 67: 1594-601. PMID 17308099 DOI: 10.1158/0008-5472.CAN-06-2673 |
0.302 |
|
2006 |
Onda M, Nagata S, FitzGerald DJ, Beers R, Fisher RJ, Vincent JJ, Lee B, Nakamura M, Hwang J, Kreitman RJ, Hassan R, Pastan I. Characterization of the B cell epitopes associated with a truncated form of Pseudomonas exotoxin (PE38) used to make immunotoxins for the treatment of cancer patients. Journal of Immunology (Baltimore, Md. : 1950). 177: 8822-34. PMID 17142785 DOI: 10.4049/Jimmunol.177.12.8822 |
0.319 |
|
2006 |
Ho M, Nagata S, Pastan I. Isolation of anti-CD22 Fv with high affinity by Fv display on human cells. Proceedings of the National Academy of Sciences of the United States of America. 103: 9637-42. PMID 16763048 DOI: 10.1073/pnas.0603653103 |
0.337 |
|
2006 |
Egland KA, Liu XF, Squires S, Nagata S, Man YG, Bera TK, Onda M, Vincent JJ, Strausberg RL, Lee B, Pastan I. High expression of a cytokeratin-associated protein in many cancers. Proceedings of the National Academy of Sciences of the United States of America. 103: 5929-34. PMID 16585525 DOI: 10.1073/Pnas.0601296103 |
0.303 |
|
2006 |
Attia P, Powell DJ, Maker AV, Kreitman RJ, Pastan I, Rosenberg SA. Selective elimination of human regulatory T lymphocytes in vitro with the recombinant immunotoxin LMB-2. Journal of Immunotherapy (Hagerstown, Md. : 1997). 29: 208-14. PMID 16531821 DOI: 10.1097/01.cji.0000187959.45803.0c |
0.301 |
|
2005 |
Yokokawa J, Palena C, Arlen P, Hassan R, Ho M, Pastan I, Schlom J, Tsang KY. Identification of novel human CTL epitopes and their agonist epitopes of mesothelin. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 11: 6342-51. PMID 16144939 DOI: 10.1158/1078-0432.CCR-05-0596 |
0.317 |
|
2005 |
Onda M, Willingham M, Nagata S, Bera TK, Beers R, Ho M, Hassan R, Kreitman RJ, Pastan I. New monoclonal antibodies to mesothelin useful for immunohistochemistry, fluorescence-activated cell sorting, Western blotting, and ELISA. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 11: 5840-6. PMID 16115924 DOI: 10.1158/1078-0432.CCR-05-0578 |
0.322 |
|
2005 |
Soler-GarcÃa AA, Maitra R, Kumar V, Ise T, Nagata S, Beers R, Bera TK, Pastan I. The PATE gene is expressed in the accessory tissues of the human male genital tract and encodes a secreted sperm-associated protein. Reproduction (Cambridge, England). 129: 515-24. PMID 15798027 DOI: 10.1530/rep.1.00576 |
0.309 |
|
2005 |
Ho M, Kreitman RJ, Onda M, Pastan I. In vitro antibody evolution targeting germline hot spots to increase activity of an anti-CD22 immunotoxin. The Journal of Biological Chemistry. 280: 607-17. PMID 15491997 DOI: 10.1074/jbc.M409783200 |
0.315 |
|
2004 |
Hassan R, Bera T, Pastan I. Mesothelin: a new target for immunotherapy. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 10: 3937-42. PMID 15217923 DOI: 10.1158/1078-0432.CCR-03-0801 |
0.312 |
|
2004 |
Maeda H, Nagata S, Wolfgang CD, Bratthauer GL, Bera TK, Pastan I. The T cell receptor gamma chain alternate reading frame protein (TARP), a prostate-specific protein localized in mitochondria. The Journal of Biological Chemistry. 279: 24561-8. PMID 15150260 DOI: 10.1074/jbc.M402492200 |
0.311 |
|
2004 |
FitzGerald DJ, Kreitman R, Wilson W, Squires D, Pastan I. Recombinant immunotoxins for treating cancer. International Journal of Medical Microbiology : Ijmm. 293: 577-82. PMID 15149034 DOI: 10.1078/1438-4221-00302 |
0.348 |
|
2004 |
Oh S, Terabe M, Pendleton CD, Bhattacharyya A, Bera TK, Epel M, Reiter Y, Phillips J, Linehan WM, Kasten-Sportes C, Pastan I, Berzofsky JA. Human CTLs to wild-type and enhanced epitopes of a novel prostate and breast tumor-associated protein, TARP, lyse human breast cancer cells. Cancer Research. 64: 2610-8. PMID 15059918 DOI: 10.1158/0008-5472.Can-03-2183 |
0.304 |
|
2004 |
Decker T, Wagner M, Oelsner M, Kreitman RJ, Pastan I, Peschel C, Licht T. BL22, a Recombinant Anti-CD22 Immunotoxin, Induces Cell Cycle Arrest and Apoptosis in B-Cell Lymphoma. Blood. 104: 4613-4613. DOI: 10.1182/BLOOD.V104.11.4613.4613 |
0.325 |
|
2002 |
McHugh L, Hu S, Lee BK, Santora K, Kennedy PE, Berger EA, Pastan I, Hamer DH. Increased affinity and stability of an anti-HIV-1 envelope immunotoxin by structure-based mutagenesis. The Journal of Biological Chemistry. 277: 34383-90. PMID 12119300 DOI: 10.1074/jbc.M205456200 |
0.31 |
|
2002 |
Salvatore G, Nagata S, Billaud M, Santoro M, Vecchio G, Pastan I. Generation and characterization of novel monoclonal antibodies to the Ret receptor tyrosine kinase. Biochemical and Biophysical Research Communications. 294: 813-7. PMID 12061779 DOI: 10.1016/S0006-291X(02)00560-0 |
0.302 |
|
2002 |
Decker T, Hipp S, Kreitman RJ, Pastan I, Peschel C, Licht T. Sensitization of B-cell chronic lymphocytic leukemia cells to recombinant immunotoxin by immunostimulatory phosphorothioate oligodeoxynucleotides. Blood. 99: 1320-6. PMID 11830482 DOI: 10.1182/blood.V99.4.1320 |
0.305 |
|
2000 |
Wolfgang CD, Essand M, Vincent JJ, Lee B, Pastan I. TARP: a nuclear protein expressed in prostate and breast cancer cells derived from an alternate reading frame of the T cell receptor gamma chain locus. Proceedings of the National Academy of Sciences of the United States of America. 97: 9437-42. PMID 10931945 DOI: 10.1073/pnas.160270597 |
0.312 |
|
2000 |
Hassan R, Viner JL, Wang QC, Margulies I, Kreitman RJ, Pastan I. Anti-tumor activity of K1-LysPE38QQR, an immunotoxin targeting mesothelin, a cell-surface antigen overexpressed in ovarian cancer and malignant mesothelioma. Journal of Immunotherapy (Hagerstown, Md. : 1997). 23: 473-9. PMID 10916757 DOI: 10.1097/00002371-200007000-00011 |
0.326 |
|
2000 |
Shen DW, Goldenberg S, Pastan I, Gottesman MM. Decreased accumulation of [14C]carboplatin in human cisplatin-resistant cells results from reduced energy-dependent uptake. Journal of Cellular Physiology. 183: 108-16. PMID 10699972 DOI: 10.1002/(Sici)1097-4652(200004)183:1<108::Aid-Jcp13>3.0.Co;2-4 |
0.302 |
|
1999 |
Chowdhury PS, Pastan I. Analysis of cloned Fvs from a phage display library indicates that DNA immunization can mimic antibody response generated by cell immunizations. Journal of Immunological Methods. 231: 83-91. PMID 10648929 DOI: 10.1016/S0022-1759(99)00142-8 |
0.304 |
|
1998 |
Bera TK, Pastan I. Comparison of recombinant immunotoxins against LeY antigen expressing tumor cells: influence of affinity, size, and stability. Bioconjugate Chemistry. 9: 736-43. PMID 9815167 DOI: 10.1021/bc980028o |
0.318 |
|
1998 |
Hrycyna CA, Airan LE, Germann UA, Ambudkar SV, Pastan I, Gottesman MM. Structural flexibility of the linker region of human P-glycoprotein permits ATP hydrolysis and drug transport. Biochemistry. 37: 13660-73. PMID 9753453 DOI: 10.1021/Bi9808823 |
0.308 |
|
1998 |
Hrycyna CA, Ramachandra M, Pastan I, Gottesman MM. Functional expression of human P-glycoprotein from plasmids using vaccinia virus-bacteriophage T7 RNA polymerase system. Methods in Enzymology. 292: 456-73. PMID 9711574 DOI: 10.1016/S0076-6879(98)92035-3 |
0.301 |
|
1998 |
Almog O, Benhar I, Vasmatzis G, Tordova M, Lee B, Pastan I, Gilliland GL. Crystal structure of the disulfide-stabilized Fv fragment of anticancer antibody B1: conformational influence of an engineered disulfide bond. Proteins. 31: 128-38. PMID 9593187 DOI: 10.1002/(Sici)1097-0134(19980501)31:2<128::Aid-Prot3>3.0.Co;2-I |
0.579 |
|
1998 |
Chowdhury PS, Viner JL, Beers R, Pastan I. Isolation of a high-affinity stable single-chain Fv specific for mesothelin from DNA-immunized mice by phage display and construction of a recombinant immunotoxin with anti-tumor activity. Proceedings of the National Academy of Sciences of the United States of America. 95: 669-74. PMID 9435250 DOI: 10.1073/Pnas.95.2.669 |
0.336 |
|
1997 |
Funatomi H, Itakura J, Ishiwata T, Pastan I, Thompson SA, Johnson GR, Korc M. Amphiregulin antisense oligonucleotide inhibits the growth of T3M4 human pancreatic cancer cells and sensitizes the cells to EGF receptor-targeted therapy. International Journal of Cancer. 72: 512-7. PMID 9247297 DOI: 10.1002/(Sici)1097-0215(19970729)72:3<512::Aid-Ijc21>3.0.Co;2-C |
0.315 |
|
1997 |
Chowdhury PS, Chang K, Pastan I. Isolation of anti-mesothelin antibodies from a phage display library. Molecular Immunology. 34: 9-20. PMID 9182872 DOI: 10.1016/S0161-5890(97)00011-4 |
0.315 |
|
1996 |
Lorimer IA, Keppler-Hafkemeyer A, Beers RA, Pegram CN, Bigner DD, Pastan I. Recombinant immunotoxins specific for a mutant epidermal growth factor receptor: targeting with a single chain antibody variable domain isolated by phage display. Proceedings of the National Academy of Sciences of the United States of America. 93: 14815-20. PMID 8962138 DOI: 10.1073/pnas.93.25.14815 |
0.328 |
|
1996 |
Ramachandra M, Ambudkar SV, Gottesman MM, Pastan I, Hrycyna CA. Functional characterization of a glycine 185-to-valine substitution in human P-glycoprotein by using a vaccinia-based transient expression system. Molecular Biology of the Cell. 7: 1485-98. PMID 8898356 DOI: 10.1091/Mbc.7.10.1485 |
0.307 |
|
1996 |
Mansfield E, Pastan I, FitzGerald DJ. Characterization of RFB4-Pseudomonas exotoxin A immunotoxins targeted to CD22 on B-cell malignancies Bioconjugate Chemistry. 7: 557-563. PMID 8889017 DOI: 10.1021/bc960043y |
0.324 |
|
1996 |
Baldwin RL, Kobrin MS, Tran T, Pastan I, Korc M. Cytotoxic effects of TGF-α-Pseudomonas exotoxin A fusion protein in human pancreatic carcinoma cells Pancreas. 13: 16-21. PMID 8783329 DOI: 10.1097/00006676-199607000-00002 |
0.32 |
|
1996 |
Li M, Dyda F, Benhar I, Pastan I, Davies DR. Crystal structure of the catalytic domain of Pseudomonas exotoxin A complexed with a nicotinamide adenine dinucleotide analog: implications for the activation process and for ADP ribosylation. Proceedings of the National Academy of Sciences of the United States of America. 93: 6902-6. PMID 8692916 DOI: 10.1073/Pnas.93.14.6902 |
0.57 |
|
1996 |
Kuan CT, Pastan I. Improved antitumor activity of a recombinant anti-Lewisy immunotoxin not requiring proteolytic activation Proceedings of the National Academy of Sciences of the United States of America. 93: 974-978. PMID 8577771 DOI: 10.1073/PNAS.93.3.974 |
0.308 |
|
1995 |
Kreitman RJ, Pastan I. Targeting Pseudomonas exotoxin to hematologic malignancies Seminars in Cancer Biology. 6: 297-306. PMID 8562907 DOI: 10.1006/SCBI.1995.0038 |
0.333 |
|
1995 |
Benhar I, Padlan EA, Jung SH, Lee B, Pastan I. Rapid humanization of the Fv of monoclonal antibody B3 by using framework exchange of the recombinant immunotoxin B3(Fv)-PE38. Proceedings of the National Academy of Sciences of the United States of America. 91: 12051-5. PMID 7991583 DOI: 10.1073/Pnas.91.25.12051 |
0.574 |
|
1995 |
Brinkmann U, Chowdhury PS, Roscoe DM, Pastan I. Phage display of disulfide-stabilized Fv fragments. Journal of Immunological Methods. 182: 41-50. PMID 7769243 DOI: 10.1016/0022-1759(95)00016-4 |
0.311 |
|
1995 |
Benhar I, Pastan I. Cloning, expression and characterization of the Fv fragments of the anti-carbohydrate mAbs B1 and B5 as single-chain immunotoxins. Protein Engineering. 7: 1509-15. PMID 7716163 DOI: 10.1093/Protein/7.12.1509 |
0.593 |
|
1995 |
Shen DW, Akiyama S, Schoenlein P, Pastan I, Gottesman MM. Characterisation of high-level cisplatin-resistant cell lines established from a human hepatoma cell line and human KB adenocarcinoma cells: cross-resistance and protein changes. British Journal of Cancer. 71: 676-83. PMID 7710928 DOI: 10.1038/Bjc.1995.134 |
0.321 |
|
1995 |
Benhar I, Reiter Y, Pai LH, Pastan I. Administration of disulfide-stabilized Fv-immunotoxins B1(dsFv)-PE38 and B3(dsFv)-PE38 by continuous infusion increases their efficacy in curing large tumor xenografts in nude mice. International Journal of Cancer. 62: 351-5. PMID 7628878 DOI: 10.1002/Ijc.2910620320 |
0.565 |
|
1995 |
Debinski W, Obiri NI, Pastan I, Puri RK. A novel chimeric protein composed of interleukin 13 and Pseudomonas exotoxin is highly cytotoxic to human carcinoma cells expressing receptors for interleukin 13 and interleukin 4 Journal of Biological Chemistry. 270: 16775-16780. PMID 7622490 DOI: 10.1074/jbc.270.28.16775 |
0.326 |
|
1995 |
Li M, Dyda F, Benhar I, Pastan I, Davies DR. The crystal structure of Pseudomonas aeruginosa exotoxin domain III with nicotinamide and AMP: conformational differences with the intact exotoxin. Proceedings of the National Academy of Sciences of the United States of America. 92: 9308-12. PMID 7568123 DOI: 10.1073/Pnas.92.20.9308 |
0.565 |
|
1995 |
Benhar I, Pastan I. Identification of residues that stabilize the single-chain Fv of monoclonal antibodies B3. The Journal of Biological Chemistry. 270: 23373-80. PMID 7559495 DOI: 10.1074/Jbc.270.40.23373 |
0.583 |
|
1994 |
Debinski W, Pastan I. An immunotoxin with increased activity and homogeneity produced by reducing the number of lysine residues in recombinant Pseudomonas exotoxin Bioconjugate Chemistry. 5: 40-46. PMID 8199233 DOI: 10.1021/Bc00025A006 |
0.302 |
|
1994 |
Puri RK, Debinski W, Obiri N, Kreitman R, Pastan I. Human Renal Cell Carcinoma Cells Are Sensitive to the Cytotoxic Effect of a Chimeric Protein Composed of Human Interleukin-4 and Pseudomonas Exotoxin Cellular Immunology. 154: 369-379. PMID 8131209 DOI: 10.1006/cimm.1994.1084 |
0.309 |
|
1994 |
Benhar I, Brinkmann U, Webber KO, Pastan I. Mutations of two lysine residues in the CDR loops of a recombinant immunotoxin that reduce its sensitivity to chemical derivatization. Bioconjugate Chemistry. 5: 321-326. PMID 7948099 DOI: 10.1021/Bc00028A007 |
0.577 |
|
1994 |
Roscoe DM, Jung SH, Benhar I, Pai L, Lee BK, Pastan I. Primate antibody response to immunotoxin: serological and computer-aided analysis of epitopes on a truncated form of Pseudomonas exotoxin. Infection and Immunity. 62: 5055-65. PMID 7927788 DOI: 10.1128/Iai.62.11.5055-5065.1994 |
0.574 |
|
1994 |
Siegall CB, Gawlak SL, Chace DF, Merwin JR, Pastan I. In vivo activities of acidic fibroblast growth factor-Pseudomonas exotoxin fusion proteins. Bioconjugate Chemistry. 5: 77-83. PMID 7515280 DOI: 10.1021/bc00025a010 |
0.322 |
|
1993 |
Brinkmann U, Gallo M, Brinkmann E, Kunwar S, Pastan I. A recombinant immunotoxin that is active on prostate cancer cells and that is composed of the Fv region of monoclonal antibody PR1 and a truncated form of Pseudomonas exotoxin. Proceedings of the National Academy of Sciences of the United States of America. 90: 547-51. PMID 8421689 DOI: 10.1073/PNAS.90.2.547 |
0.313 |
|
1993 |
Kunwar S, Pai LH, Pastan I. Cytotoxicity and antitumor effects of growth factor-toxin fusion proteins on human glioblastoma multiforme cells. Journal of Neurosurgery. 79: 569-76. PMID 7692018 DOI: 10.3171/jns.1993.79.4.0569 |
0.325 |
|
1992 |
Kreitman RJ, Siegall CB, Chaudhary VK, FitzGerald DJ, Pastan I. Properties of chimeric toxins with two recognition domains: interleukin 6 and transforming growth factor alpha at different locations in Pseudomonas exotoxin. Bioconjugate Chemistry. 3: 63-8. PMID 1616951 DOI: 10.1021/bc00013a010 |
0.308 |
|
1992 |
Batra JK, Kasprzyk PG, Bird RE, Pastan I, King CR. Recombinant anti-erbB2 immunotoxins containing Pseudomonas exotoxin. Proceedings of the National Academy of Sciences of the United States of America. 89: 5867-71. PMID 1352878 DOI: 10.1073/Pnas.89.13.5867 |
0.331 |
|
1992 |
Chin KV, Chauhan SS, Abraham I, Sampson KE, Krolczyk AJ, Wong M, Schimmer B, Pastan I, Gottesman MM. Reduced mRNA levels for the multidrug-resistance genes in cAMP-dependent protein kinase mutant cell lines. Journal of Cellular Physiology. 152: 87-94. PMID 1352302 DOI: 10.1002/Jcp.1041520112 |
0.312 |
|
1992 |
Biro S, Siegall CB, Fu YM, Speir E, Pastan I, Epstein SE. In vitro effects of a recombinant toxin targeted to the fibroblast growth factor receptor on rat vascular smooth muscle and endothelial cells. Circulation Research. 71: 640-5. PMID 1323436 DOI: 10.1161/01.RES.71.3.640 |
0.301 |
|
1991 |
Batra JK, Fitzgerald DJ, Chaudhary VK, Pastan I. Single-chain immunotoxins directed at the human transferrin receptor containing Pseudomonas exotoxin A or diphtheria toxin: anti-TFR(Fv)-PE40 and DT388-anti-TFR(Fv). Molecular and Cellular Biology. 11: 2200-5. PMID 2005905 DOI: 10.1128/mcb.11.4.2200 |
0.329 |
|
1991 |
Epstein SE, Siegall CB, Biro S, Fu YM, FitzGerald D, Pastan I. Cytotoxic effects of a recombinant chimeric toxin on rapidly proliferating vascular smooth muscle cells. Circulation. 84: 778-87. PMID 1860221 DOI: 10.1161/01.CIR.84.2.778 |
0.324 |
|
1990 |
Batra JK, Chaudhary VK, FitzGerald D, Pastan I. TGF alpha-anti-Tac(Fv)-PE40: a bifunctional toxin cytotoxic for cells with EGF or IL2 receptors. Biochemical and Biophysical Research Communications. 171: 1-6. PMID 2393383 DOI: 10.1016/0006-291x(90)91347-u |
0.315 |
|
1990 |
Chaudhary VK, Gallo MG, FitzGerald DJ, Pastan I. A recombinant single-chain immunotoxin composed of anti-Tac variable regions and a truncated diphtheria toxin. Proceedings of the National Academy of Sciences of the United States of America. 87: 9491-4. PMID 2251289 DOI: 10.1073/pnas.87.23.9491 |
0.321 |
|
1990 |
Kreitman RJ, Chaudhary VK, Waldmann T, Willingham MC, FitzGerald DJ, Pastan I. The recombinant immunotoxin anti-Tac(Fv)-Pseudomonas exotoxin 40 is cytotoxic toward peripheral blood malignant cells from patients with adult T-cell leukemia. Proceedings of the National Academy of Sciences of the United States of America. 87: 8291-5. PMID 2236041 DOI: 10.1073/Pnas.87.21.8291 |
0.324 |
|
1990 |
Chaudhary VK, Batra JK, Gallo MG, Willingham MC, FitzGerald DJ, Pastan I. A rapid method of cloning functional variable-region antibody genes in Escherichia coli as single-chain immunotoxins. Proceedings of the National Academy of Sciences of the United States of America. 87: 1066-70. PMID 2105495 DOI: 10.1073/pnas.87.3.1066 |
0.313 |
|
1989 |
Siegall CB, Xu YH, Chaudhary VK, Adhya S, Fitzgerald D, Pastan I. Cytotoxic activities of a fusion protein comprised of TGF alpha and Pseudomonas exotoxin. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. 3: 2647-52. PMID 2556314 DOI: 10.1096/Fasebj.3.14.2556314 |
0.31 |
|
1989 |
Batra JK, Jinno Y, Chaudhary VK, Kondo T, Willingham MC, FitzGerald DJ, Pastan I. Antitumor activity in mice of an immunotoxin made with anti-transferrin receptor and a recombinant form of Pseudomonas exotoxin. Proceedings of the National Academy of Sciences of the United States of America. 86: 8545-9. PMID 2510169 DOI: 10.1073/pnas.86.21.8545 |
0.324 |
|
1989 |
Chaudhary VK, Queen C, Junghans RP, Waldmann TA, FitzGerald DJ, Pastan I. A recombinant immunotoxin consisting of two antibody variable domains fused to Pseudomonas exotoxin. Nature. 339: 394-7. PMID 2498664 DOI: 10.1038/339394A0 |
0.318 |
|
1988 |
Kane SE, Troen BR, Gal S, Ueda K, Pastan I, Gottesman MM. Use of cloned multidrug resistance gene for coamplification and overproduction of major excreted protein,a transformation-regulated secreted acid protease Molecular and Cellular Biology. 8: 3316-3321. PMID 2463474 DOI: 10.1128/Mcb.8.8.3316 |
0.322 |
|
1987 |
Hasumura S, Kitagawa S, Lovelace E, Willingham MC, Pastan I, Cheng S. Characterization of a membrane-associated 3,3',5-triiodo-L-thyronine binding protein by use of monoclonal antibodies. Biochemistry. 25: 7881-8. PMID 3542039 DOI: 10.1021/bi00372a014 |
0.313 |
|
1987 |
Chaudhary VK, FitzGerald DJ, Adhya S, Pastan I. Activity of a recombinant fusion protein between transforming growth factor type alpha and Pseudomonas toxin. Proceedings of the National Academy of Sciences of the United States of America. 84: 4538-42. PMID 3299371 DOI: 10.1073/Pnas.84.13.4538 |
0.314 |
|
1986 |
Cheng SY, Hasumura S, Willingham MC, Pastan I. Purification and characterization of a membrane-associated 3,3',5-triiodo-L-thyronine binding protein from a human carcinoma cell line. Proceedings of the National Academy of Sciences of the United States of America. 83: 947-51. PMID 3006034 DOI: 10.1073/pnas.83.4.947 |
0.303 |
|
1986 |
King CR, Kraus MH, Williams LT, Merlino GT, Pastan IH, Aaronson SA. Human tumor cell lines with EGF receptor gene amplification in the absence of aberrant sized mRNAs. Nucleic Acids Research. 13: 8477-86. PMID 3001641 DOI: 10.1093/Nar/13.23.8477 |
0.56 |
|
1986 |
Pastan I, Hanover J, Willingham M. The cellular entry of EGF and transferrin: a problem in intracellular sorting. Current Topics in Cellular Regulation. 26: 17-25. PMID 3000694 DOI: 10.1016/B978-0-12-152826-3.50009-7 |
0.501 |
|
1986 |
Hanover JA, D'Souza P, August T, Pastan I, Willingham MC. Monoclonal antibodies against a glycoprotein localized in coated pits and endocytic vesicles inhibit α2-macroglobulin binding and uptake Journal of Biological Chemistry. 261: 16732-16737. PMID 2430970 |
0.533 |
|
1985 |
Hanover JA, Pastan I, Willingham MC. Inhibition of phosphatidylcholine synthesis does not alter uptake of transferrin by LM fibroblasts Experimental Cell Research. 157: 276-281. PMID 3972013 DOI: 10.1016/0014-4827(85)90170-3 |
0.551 |
|
1985 |
Pirker R, FitzGerald DJP, Hamilton TC, Ozols RF, Laird W, Frankel AE, Willingham MC, Pastan I. Characterization of immunotoxins active against ovarian cancer cell lines Journal of Clinical Investigation. 76: 1261-1267. PMID 3930572 DOI: 10.1172/Jci112082 |
0.317 |
|
1985 |
Akiyama Si, Fojo A, Hanover JA, Pastan I, Gottesman MM. Isolation and genetic characterization of human KB cell lines resistant to multiple drugs Somatic Cell and Molecular Genetics. 11: 117-126. PMID 3856953 DOI: 10.1007/BF01534700 |
0.519 |
|
1985 |
Hunts JH, Shimizu N, Yamamoto T, Toyoshima K, Merlino GT, Xu YH, Pastan I. Translocation chromosome 7 of A431 cells contains amplification and rearrangement of EGF receptor gene responsible for production of variant mRNA. Somatic Cell and Molecular Genetics. 11: 477-84. PMID 2994239 DOI: 10.1007/Bf01534841 |
0.302 |
|
1985 |
Hanover JA, Beguinot L, Willingham MC, Pastan IH. Transit of receptors for epidermal growth factor and transferrin through clathrin-coated pits. Analysis of the kinetics of receptor entry Journal of Biological Chemistry. 260: 15938-15945. PMID 2866188 |
0.492 |
|
1985 |
Beguinot L, Hanover JA, Ito S, Richert ND, Willingham MC, Pastan I. Phorbol esters induce transient internalization without degradation of unoccupied epidermal growth factor receptors Proceedings of the National Academy of Sciences of the United States of America. 82: 2774-2778. PMID 2859591 DOI: 10.1073/Pnas.82.9.2774 |
0.559 |
|
1985 |
Dickson RB, Hanover JA, Pastan I, Willingham MC. Isolation of receptosomes (endosomes) from human KB cells Methods in Enzymology. 257-271. PMID 2859514 DOI: 10.1016/0076-6879(85)09091-7 |
0.573 |
|
1984 |
Xu YH, Ishii S, Clark AJ, Sullivan M, Wilson RK, Ma DP, Roe BA, Merlino GT, Pastan I. Human epidermal growth factor receptor cDNA is homologous to a variety of RNAs overproduced in A431 carcinoma cells. Nature. 309: 806-10. PMID 6330563 DOI: 10.1038/309806a0 |
0.311 |
|
1984 |
McKeon C, Pastan I, de Crombrugghe B. DNase I sensitivity of the alpha 2(I) collagen gene: correlation with its expression but not with its methylation pattern. Nucleic Acids Research. 12: 3491-502. PMID 6328424 DOI: 10.1093/nar/12.8.3491 |
0.553 |
|
1984 |
Hanover JA, Willingham MC, Pastan I. Kinetics of transit of transferrin and epidermal growth factor through clathrin-coated membranes Cell. 39: 283-293. PMID 6149810 DOI: 10.1016/0092-8674(84)90006-0 |
0.546 |
|
1984 |
Willingham MC, Strader CD, Lefkowitz RJ, Pastan I. Morphologic demonstration of clathrin-coated pits in frog and turkey erythrocytes. Experimental Cell Research. 151: 573-7. PMID 6142826 DOI: 10.1016/0014-4827(84)90406-3 |
0.453 |
|
1984 |
Willingham MC, Hanover JA, Dickson RB, Pastan I. Morphologic characterization of the pathway of transferrin endocytosis and recycling in human KB cells Proceedings of the National Academy of Sciences of the United States of America. 81: 175-179. PMID 6141558 DOI: 10.1073/pnas.81.1.175 |
0.576 |
|
1984 |
Akiyama T, Yamada Y, Ogawara H, Richert N, Pastan I, Yamamoto T, Kasuga M. Site-specific antibodies to the erbB oncogene product immunoprecipitate epidermal growth factor receptor. Biochemical and Biophysical Research Communications. 123: 797-802. PMID 6091642 DOI: 10.1016/0006-291X(84)90300-0 |
0.302 |
|
1984 |
Akiyama S, Gottesman MM, Hanover JA, Fitzgerald DJ, Willingham MC, Pastan I. Verapamil enhances the toxicity of conjugates of epidermal growth factor with Pseudomonas exotoxin and antitransferrin receptor with Pseudomonas exotoxin Journal of Cellular Physiology. 120: 271-279. PMID 6086678 DOI: 10.1002/jcp.1041200303 |
0.573 |
|
1983 |
Hanover JA, Rudick JE, Willingham MC, Pastan I. α2-macroglobulin binding to cultured fibroblasts: Identification by affinity chromatography of high-affinity binding sites Archives of Biochemistry and Biophysics. 227: 570-579. PMID 6667030 DOI: 10.1016/0003-9861(83)90486-1 |
0.553 |
|
1983 |
Hirano H, Yamada Y, Sullivan M, de Crombrugghe B, Pastan I, Yamada KM. Isolation of genomic DNA clones spanning the entire fibronectin gene. Proceedings of the National Academy of Sciences of the United States of America. 80: 46-50. PMID 6572007 DOI: 10.1073/pnas.80.1.46 |
0.633 |
|
1983 |
Dickson RB, Hanover JA, Willingham MC, Pastan I. Prelysosomal divergence of transferrin and epidermal growth factor during receptor-mediated endocytosis Biochemistry. 22: 5667-5674. PMID 6317024 DOI: 10.1021/Bi00293A033 |
0.549 |
|
1983 |
Dickson RB, Beguinot L, Hanover JA, Richert ND, Willingham MC, Pastan I. Isolation and characterization of a highly enriched preparation of receptosomes (endosomes) from a human cell line Proceedings of the National Academy of Sciences of the United States of America. 80: 5335-5339. PMID 6310570 DOI: 10.1073/Pnas.80.17.5335 |
0.572 |
|
1983 |
FitzGerald DJ, Trowbridge IS, Pastan I, Willingham MC. Enhancement of toxicity of antitransferrin receptor antibody-Pseudomonas exotoxin conjugates by adenovirus. Proceedings of the National Academy of Sciences of the United States of America. 80: 4134-8. PMID 6306663 DOI: 10.1073/Pnas.80.13.4134 |
0.305 |
|
1983 |
Hanover JA, Willingham MC, Pastan I. Receptor-mediated endocytosis of α2-macroglobulin: Solubilization and partial purification of the fibroblast α2-macroglobulin receptor Annals of the New York Academy of Sciences. 410-423. PMID 6202215 DOI: 10.1111/J.1749-6632.1983.Tb18135.X |
0.566 |
|
1983 |
Merlino GT, McKeon C, de Crombrugghe B, Pastan I. Regulation of the expression of genes encoding types I, II, and III collagen during chick embryonic development. The Journal of Biological Chemistry. 258: 10041-8. PMID 6193105 |
0.505 |
|
1983 |
Hanover JA, Cheng S, Willingham MC, Pastan IH. α2-Macroglobulin binding to cultured fibroblasts. Solubilization and partial purification of binding sites Journal of Biological Chemistry. 258: 370-377. PMID 6184373 |
0.51 |
|
1982 |
Tyagi JS, Merlino GT, de Crombrugghe B, Pastan I. Chicken embryo extracts contain a factor that preferentially blocks the accumulation of RNA polymerase II transcripts in a cell-free system. The Journal of Biological Chemistry. 257: 13001-8. PMID 7130191 |
0.513 |
|
1982 |
Vogeli G, Ohkubo H, Sobel ME, Yamada Y, Pastan I, de Crombrugghe B. Structure of the promoter for chicken α2 type I collagen gene Proceedings of the National Academy of Sciences of the United States of America. 78: 5334-5338. PMID 6946474 DOI: 10.1073/pnas.78.9.5334 |
0.55 |
|
1982 |
Gorman CM, Merlino GT, Willingham MC, Pastan I, Howard BH. The Rous sarcoma virus long terminal repeat is a strong promoter when introduced into a variety of eukaryotic cells by DNA-mediated transfection Proceedings of the National Academy of Sciences of the United States of America. 79: 6777-6781. PMID 6294651 DOI: 10.1073/pnas.79.22.6777 |
0.332 |
|
1982 |
Horiuchi R, Johnson ML, Willingham MC, Pastan I, Cheng S. Affinity labeling of the plasma membrane 3,3',5-triiodo-L-thyronine receptor in GH3 cells. Proceedings of the National Academy of Sciences of the United States of America. 79: 5527-31. PMID 6291049 DOI: 10.1073/pnas.79.18.5527 |
0.315 |
|
1982 |
Pastan IH, Willingham M, de Crombrugghe B, Gottesman MM. Aging and cancer: cyclic 3', 5'-adenosine monophosphate and altered gene activity. National Cancer Institute Monograph. 60: 7-15. PMID 6289108 |
0.452 |
|
1982 |
Merlino GT, Tyagi JS, de Crombrugghe B, Pastan I. Transcription of the chicken alpha 2 (Type I) collagen gene by homologous cell-free extracts. The Journal of Biological Chemistry. 257: 7254-61. PMID 6282836 |
0.533 |
|
1981 |
Pretorius HT, Nandi PK, Lippoldt RE, Johnson ML, Keen JH, Pastan I, Edelhoch H. Molecular characterization of human clathrin. Biochemistry. 20: 2777-82. PMID 7248247 DOI: 10.1021/Bi00513A011 |
0.549 |
|
1981 |
Vogeli G, Ohkubo H, Avvedimento VE, Sullivan M, Yamada Y, Mudryj M, Pastan I, de Crombrugghe B. A repetitive structure in the chick alpha 2-collagen gene. Cold Spring Harbor Symposia On Quantitative Biology. 45: 777-83. PMID 6942950 DOI: 10.1101/Sqb.1981.045.01.096 |
0.531 |
|
1981 |
Merlino GT, Vogeli G, Yamamoto T, de Crombrugghe B, Pastan I. Accurate in vitro transcriptional initiation of the chick alpha 2 (Type I) collagen gene. The Journal of Biological Chemistry. 256: 11251-8. PMID 6270147 |
0.519 |
|
1981 |
Dickson LA, Ninomiya Y, Bernard MP, Pesciotta DM, Parsons J, Green G, Eikenberry EF, de Crombrugghe B, Vogeli G, Pastan I, Fietzek PP, Olsen BR. The exon/intron structure of the 3'-region of the pro alpha 2(I) collagen gene. The Journal of Biological Chemistry. 256: 8407-15. PMID 6267043 |
0.486 |
|
1981 |
Sobel ME, Yamamoto T, De Crombrugghe B, Pastan I. Regulation of procollagen messenger ribonucleic acid levels in Rous sarcoma virus transformed chick embryo fibroblasts Biochemistry. 20: 2678-2684. PMID 6263317 DOI: 10.1021/Bi00512A049 |
0.554 |
|
1981 |
Fagan JB, Sobel ME, Yamada KM, de Crombrugghe B, Pastan I. Effects of transformation on fibronectin gene expression using cloned fibronectin cDNA Journal of Biological Chemistry. 256: 520-525. PMID 6256355 |
0.474 |
|
1981 |
Maxfield FR, Willingham MC, Pastan I, Dragsten P, Cheng SY. Binding and mobility of the cell surface receptors for 3,3',5-triiodo-L-thyronine. Science (New York, N.Y.). 211: 63-5. PMID 6255563 |
0.479 |
|
1981 |
Maxfield FR, Willingham MC, Haigler HT, Dragsten P, Pastan IH. Binding, surface mobility, internalization, and degradation of rhodamine-labeled alpha 2-macroglobulin. Biochemistry. 20: 5353-8. PMID 6170323 DOI: 10.1021/Bi00521A041 |
0.487 |
|
1980 |
Yamada Y, Avvedimento VE, Mudryj M, Ohkubo H, Vogeli G, Irani M, Pastan I, de Crombrugghe B. The collagen gene: evidence for its evolutinary assembly by amplification of a DNA segment containing an exon of 54 bp. Cell. 22: 887-92. PMID 7460017 DOI: 10.1016/0092-8674(80)90565-6 |
0.544 |
|
1980 |
Vogeli G, Avvedimento EV, Sullivan M, Maizel JV, Lozano G, Adams SL, Pastan I, de Crombrugghe B. Isolation and characterization of genomic DNA coding for α2 type I collagen Nucleic Acids Research. 8: 1823-1837. PMID 7433131 DOI: 10.1093/Nar/8.8.1823 |
0.544 |
|
1980 |
Haigler HT, Willingham MC, Pastan I. Inhibitors of 125I-epidermal growth factor internalization Biochemical and Biophysical Research Communications. 94: 630-637. PMID 6967318 DOI: 10.1016/0006-291X(80)91279-6 |
0.323 |
|
1980 |
Ohkubo H, Vogeli G, Mudryj M, Avvedimento VE, Sullivan M, Pastan I, de Crombrugghe B. Isolation and characterization of overlapping genomic clones covering the chicken alpha 2 (type I) collagen gene. Proceedings of the National Academy of Sciences of the United States of America. 77: 7059-63. PMID 6452631 DOI: 10.1073/Pnas.77.12.7059 |
0.557 |
|
1980 |
Yamamoto T, de Crombrugghe B, Pastan I. Identification of a functional promoter in the long terminal repeat of Rous sarcoma virus. Cell. 22: 787-97. PMID 6257399 DOI: 10.1016/0092-8674(80)90555-3 |
0.553 |
|
1980 |
Yamamoto T, Sobel ME, Adams SL, Avvedimento VE, DiLauro R, Pastan I, de Crombrugghe B, Showalter A, Pesciotta D, Fietzek P, Olsen B. Construction of a recombinant bacterial plasmid containing pro-α1(I) collagen DNA sequences Journal of Biological Chemistry. 255: 2612-2615. PMID 6244285 |
0.474 |
|
1980 |
Haigler HT, Maxfield FR, Willingham MC, Pastan I. Dansylcadaverine inhibits internalization of 125I-epidermal growth factor in BALB 3T3 cells. The Journal of Biological Chemistry. 255: 1239-41. PMID 6243633 |
0.506 |
|
1980 |
Willingham MC, Maxfield FR, Pastan I. Receptor-mediated endocytosis of alpha 2-macroglobulin in cultured fibroblasts. The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society. 28: 818-23. PMID 6160180 DOI: 10.1177/28.8.6160180 |
0.554 |
|
1980 |
Avvedimento VE, Vogeli G, Yamada Y, Maizel JV, Pastan I, de Crombrugghe B. Correlation between splicing sites within an intron and their sequence complementarity with U1 RNA. Cell. 21: 689-96. PMID 6159982 DOI: 10.1016/0092-8674(80)90432-8 |
0.543 |
|
1980 |
Cheng SY, Maxfield FR, Robbins J, Willingham MC, Pastan IH. Receptor-mediated uptake of 3,3',5-triiodo-L-thyronine by cultured fibroblasts. Proceedings of the National Academy of Sciences of the United States of America. 77: 3425-9. PMID 6158047 DOI: 10.1073/Pnas.77.6.3425 |
0.488 |
|
1980 |
Davies PJ, Davies DR, Levitzki A, Maxfield FR, Milhaud P, Willingham MC, Pastan IH. Transglutaminase is essential in receptor-mediated endocytosis of alpha 2-macroglobulin and polypeptide hormones. Nature. 283: 162-7. PMID 6153122 DOI: 10.1038/283162A0 |
0.48 |
|
1979 |
Fagan JB, Yamada KM, de Crombrugghe B, Pastan I. Partial purification and characterization of the messenger RNA for cell fibronectin. Nucleic Acids Research. 6: 3471-80. PMID 573888 DOI: 10.1093/nar/6.11.3471 |
0.619 |
|
1979 |
Yamada KM, Olden K, Pastan I. Transformation-sensitive cell surface protein: isolation, characterization, and role in cellular morphology and adhesion. Annals of the New York Academy of Sciences. 312: 256-77. PMID 291364 DOI: 10.1111/j.1749-6632.1978.tb16807.x |
0.516 |
|
1979 |
LeCam A, Maxfield F, Willingham M, Pastan I. Insulin stimulation of amino acid transport in isolated rat hepatocytes is independent of hormone internalization. Biochemical and Biophysical Research Communications. 88: 873-81. PMID 223575 DOI: 10.1016/0006-291X(79)91490-6 |
0.516 |
|
1979 |
Willingham MC, Maxfield FR, Pastan IH. alpha 2 Macroglobulin binding to the plasma membrane of cultured fibroblasts. Diffuse binding followed by clustering in coated regions. The Journal of Cell Biology. 82: 614-25. PMID 92473 DOI: 10.1083/Jcb.82.3.614 |
0.484 |
|
1979 |
Maxfield FR, Willingham MC, Davies PJ, Pastan I. Amines inhibit the clustering of alpha2-macroglobulin and EGF on the fibroblast cell surface. Nature. 277: 661-3. PMID 85262 DOI: 10.1038/277661A0 |
0.539 |
|
1979 |
Maxfield FR, Davies PJ, Klempner L, Willingham MC, Pastan I. Epidermal growth factor stimulation of DNA synthesis is potentiated by compounds that inhibit its clustering in coated pits. Proceedings of the National Academy of Sciences of the United States of America. 76: 5731-5. PMID 42903 DOI: 10.1073/Pnas.76.11.5731 |
0.547 |
|
1978 |
Yamada KM, Schlesinger DH, Kennedy DW, Pastan I. Characterization of a major fibroblast cell surface glycoprotein. Biochemistry. 16: 5552-9. PMID 562674 DOI: 10.1021/bi00644a025 |
0.477 |
|
1978 |
Sobel ME, Yamamoto T, Adams SL, DiLauro R, Avvedimento VE, de Crombrugghe B, Pastan I. Construction of a recombinant bacterial plasmid containing a chick pro-α2 collagen gene sequence Proceedings of the National Academy of Sciences of the United States of America. 75: 5846-5850. PMID 366605 DOI: 10.1073/Pnas.75.12.5846 |
0.556 |
|
1978 |
Pratt RM, Pastan I. Decreased binding of epidermal growth factor to BALB/c 3T3 mutant cells defective in glycoprotein synthesis. Nature. 272: 68-70. PMID 305006 DOI: 10.1038/272068A0 |
0.338 |
|
1978 |
Maxfield FR, Schlessinger J, Shechter Y, Pastan I, Willingham MC. Collection of insulin, EGF and alpha2-macroglobulin in the same patches on the surface of cultured fibroblasts and common internalization. Cell. 14: 805-10. PMID 80283 DOI: 10.1016/0092-8674(78)90336-7 |
0.545 |
|
1978 |
Howard BH, Adams SL, Sobel ME, Pastan I, de Crombrugghe B. Decreased levels of collagen mRNA in Rous sarcoma virus-transformed chick embryo fibroblasts Journal of Biological Chemistry. 253: 5869-5874. PMID 78927 |
0.508 |
|
1977 |
Willingham MC, Yamada KM, Yamada SS, Pouysségur J, Pastan I. Microfilament bundles and cell shape are related to adhesiveness to substratum and are dissociable from growth control in cultured fibroblasts. Cell. 10: 375-80. PMID 557370 DOI: 10.1016/0092-8674(77)90024-1 |
0.487 |
|
1977 |
Schlessinger J, Barak LS, Hammes GG, Yamada KM, Pastan I, Webb WW, Elson EL. Mobility and distribution of a cell surface glycoprotein and its interaction with other membrane components. Proceedings of the National Academy of Sciences of the United States of America. 74: 2909-13. PMID 331320 DOI: 10.1073/Pnas.74.7.2909 |
0.494 |
|
1977 |
Yamada KM, Yamada SS, Pastan I. Quantitation of a transformation-sensitive, adhesive cell surface glycoprotein. Decrease of several untransformed permanent cell lines. The Journal of Cell Biology. 74: 649-54. PMID 328519 DOI: 10.1083/jcb.74.2.649 |
0.497 |
|
1977 |
Adams SL, Sobel ME, Howard BH, Olden K, Yamada KM, de Crombrugghe B, Pastan I. Levels of translatable mRNAs for cell surface protein, collagen precursors, and two membrane proteins are altered in Rous sarcoma virus transformed chick embryo fibroblasts Proceedings of the National Academy of Sciences of the United States of America. 74: 3399-3403. PMID 198783 DOI: 10.1073/pnas.74.8.3399 |
0.645 |
|
1977 |
Yamada KM, Pastan I. The relationship between cell surface protein and glucose and alpha-aminoisobutyrate transport in transformed chick and mouse cells. Journal of Cellular Physiology. 89: 827-9. PMID 188852 DOI: 10.1002/jcp.1040890450 |
0.483 |
|
1976 |
Yamada KM, Yamada SS, Pastan I. The major cell surface glycoprotein of chick embryo fibroblasts is an agglutinin. Proceedings of the National Academy of Sciences of the United States of America. 72: 3158-62. PMID 1059102 DOI: 10.1073/pnas.72.8.3158 |
0.505 |
|
1976 |
Thomopoulos P, Roth J, Lovelace E, Pastan I. Insulin receptors in normal and transformed fibroblasts: relationship to growth and transformation Cell. 8: 417-423. PMID 954096 DOI: 10.1016/0092-8674(76)90154-9 |
0.348 |
|
1976 |
Yamada KM, Yamada SS, Pastan I. Cell surface protein partially restores morphology, adhesiveness, and contact inhibition of movement to transformed fibroblasts. Proceedings of the National Academy of Sciences of the United States of America. 73: 1217-21. PMID 177979 DOI: 10.1073/pnas.73.4.1217 |
0.495 |
|
1976 |
Yamada KM, Ohanian SH, Pastan I. Cell surface protein decreases microvilli and ruffles on transformed mouse and chick cells. Cell. 9: 241-5. PMID 61821 DOI: 10.1016/0092-8674(76)90115-X |
0.49 |
|
1974 |
Musso RE, de Crombrugghe B, Pastan I, Sklar J, Yot P, Weissman S. The 5'-terminal nucleotide sequence of galactose messenger ribonucleic acid of Escherichia coli. Proceedings of the National Academy of Sciences of the United States of America. 71: 4940-4. PMID 4612533 DOI: 10.1073/pnas.71.12.4940 |
0.512 |
|
1973 |
De Crombrugghe B, Pastan I. Regulation of gene expression by cyclic AMP in Escherichia coli. Symposia of the Society For Experimental Biology. 27: 365-9. PMID 4358368 |
0.476 |
|
1973 |
De Crombrugghe B, Pastan I, Shaw WV, Rosner JL. Stimulation by cyclic AMP and ppGpp of chloramphenicol acetyl transferase synthesis. Nature: New Biology. 241: 237-9. PMID 4349357 DOI: 10.1038/newbio241237a0 |
0.535 |
|
1973 |
De Crombrugghe B, Adhya S, Gottesman M, Pastan I. Effect of Rho on transcription of bacterial operons. Nature: New Biology. 241: 260-4. PMID 4348358 DOI: 10.1038/Newbio241260A0 |
0.532 |
|
1972 |
Stadtman ER, Stadtman TC, Pastan I, Smith LD. Clostridium barkeri sp. n. Journal of Bacteriology. 110: 758-60. PMID 4553843 DOI: 10.1128/Jb.110.2.758-760.1972 |
0.381 |
|
1972 |
Pastan I, De Crombrugghe B. Control of expression of genetic information in E. coli by cyclic AMP. Acta Endocrinologica. Supplementum. 168: 298-306. PMID 4342943 DOI: 10.1530/acta.0.071s298 |
0.501 |
|
1972 |
Johnson GS, Pastan I. N 6 ,O 2 '-dibutyryl adenosine 3',5'-monophosphate induces pigment production in melanoma cells Nature: New Biology. 237: 267-268. PMID 4338725 DOI: 10.1038/NEWBIO237267A0 |
0.307 |
|
1972 |
D'Armiento M, Johnson GS, Pastan I. Regulation of adenosine 3',5'-cyclic monophosphate phosphodiesterase activity in fibroblasts by intracellular concentrations of cyclic adenosine monophosphate (3T3-dibutyryl cyclic AMP-SV40-transformed cells-michaelis constants-L cells-prostaglandin E 1 ) Proceedings of the National Academy of Sciences of the United States of America. 69: 459-462. PMID 4333987 DOI: 10.1073/Pnas.69.2.459 |
0.307 |
|
1971 |
Pastan I, Perlman RL, Emmer M, Varmus HE, DeCrombrugghe B, Chen BP, Parks J. Regulation of gene expression in Escherichia coli by cyclic AMP. Recent Progress in Hormone Research. 27: 421-32. PMID 4336400 DOI: 10.1016/B978-0-12-571127-2.50034-1 |
0.509 |
|
1971 |
Lefkowitz RJ, Roth J, Pastan I. ACTH-receptor interaction in the adrenal: a model for the initial step in the action of hormones that stimulate adenyl cyclase. Annals of the New York Academy of Sciences. 185: 195-209. PMID 4330491 DOI: 10.1111/J.1749-6632.1971.Tb45249.X |
0.472 |
|
1971 |
Johnson GS, Pastan I. Change in growth and morphology of fibroblasts by prostaglandins Journal of the National Cancer Institute. 47: 1357-1364. PMID 4330467 DOI: 10.1093/jnci/47.6.1357 |
0.305 |
|
1971 |
Chen B, de Crombrugghe B, Anderson WB, Gottesman ME, Pastan I, Perlman RL. On the mechanism of action of lac repressor. Nature: New Biology. 233: 67-70. PMID 4330295 DOI: 10.1038/newbio233067a0 |
0.537 |
|
1971 |
De Crombrugghe B, Chen B, Anderson W, Nissley P, Gottesman M, Pastan I, Perlman R. Lac DNA, RNA polymerase and cyclic AMP receptor protein, cyclic AMP, lac repressor and inducer are the essential elements for controlled lac transcription. Nature: New Biology. 231: 139-42. PMID 4326354 DOI: 10.1038/newbio231139a0 |
0.566 |
|
1971 |
Miller Z, Varmus HE, Parks JS, Perlman RL, Pastan I. Regulation of gal messenger ribonucleic acid synthesis in Escherichia coli by 3',5'-cyclic adenosine monophosphate. The Journal of Biological Chemistry. 246: 2898-903. PMID 4324343 |
0.399 |
|
1971 |
Varmus HE, Perlman RL, Pastan I. Regulation of lac transcription in antibiotic-treated E. coli. Nature: New Biology. 230: 41-4. PMID 4324113 DOI: 10.1038/Newbio230041A0 |
0.477 |
|
1971 |
De Crombrugghe B, Chen B, Gottesman M, Pastan I, Varmus HE, Emmer M, Perlman RL. Regulation of lac mRNA synthesis in a soluble cell-free system. Nature: New Biology. 230: 37-40. PMID 4324112 DOI: 10.1038/Newbio230037A0 |
0.645 |
|
1971 |
Johnson GS, Friedman RM, Pastan I. Restoration of several morphological characteristics of normal fibroblasts in sarcoma cells treated with adenosine-3':5'-cyclic monphosphate and its derivatives. Proceedings of the National Academy of Sciences of the United States of America. 68: 425-9. PMID 4322609 DOI: 10.1073/Pnas.68.2.425 |
0.313 |
|
1970 |
Varmus HE, Perlman RL, Pastan I. Regulation of lac transcription in Escherichia coli by cyclic adenosine 3',5'-monophosphate. Studies with deoxyribonucleic acid-ribonucleic acid hybridization and hybridization competition. The Journal of Biological Chemistry. 245: 6366-72. PMID 4320837 |
0.394 |
|
1970 |
Lefkowitz RJ, Roth J, Pastan I. Effects of calcium on ACTH stimulation of the adrenal: separation of hormone binding from adenyl cyclase activation. Nature. 228: 864-6. PMID 4320054 DOI: 10.1038/228864A0 |
0.471 |
|
1970 |
Lefkowitz RJ, Roth J, Pastan I. Radioreceptor assay of adrenocorticotropic hormone: new approach to assay of polypeptide hormones in plasma. Science (New York, N.Y.). 170: 633-5. PMID 4319388 DOI: 10.1126/Science.170.3958.633 |
0.487 |
|
1970 |
Lefkowitz RJ, Roth J, Pricer W, Pastan I. ACTH receptors in the adrenal: specific binding of ACTH-125I and its relation to adenyl cyclase. Proceedings of the National Academy of Sciences of the United States of America. 65: 745-52. PMID 4315615 DOI: 10.1073/Pnas.65.3.745 |
0.496 |
|
1970 |
Varmus HE, Perlman RL, Pastan I. Regulation of lac messenger ribonucleic acid synthesis by cyclic adenosine 3',5'-monophosphate and glucose. The Journal of Biological Chemistry. 245: 2259-67. PMID 4315149 |
0.375 |
|
1970 |
de Crombrugghe B, Varmus HE, Perlman RL, Pastan IH. Stimulation of lac mRNA synthesis by cyclic AMP in cell free extracts of Escherichia coli. Biochemical and Biophysical Research Communications. 38: 894-901. PMID 4314384 DOI: 10.1016/0006-291X(70)90805-3 |
0.606 |
|
1970 |
Perlman R, Chen B, deCrombrugghe B, Emmer M, Gottesman M, Varmus H, Pastan I. The Regulation of lac Operon Transcription by Cyclic Adenosine 3', 5'-Monophosphate Cold Spring Harbor Symposia On Quantitative Biology. 35: 419-423. DOI: 10.1101/Sqb.1970.035.01.054 |
0.463 |
|
1969 |
De Crombrugghe B, Perlman RL, Varmus HE, Pastan I. Regulation of inducible enzyme synthesis in Escherichia coli by cyclic adenosine 3', 5'-monophosphate. The Journal of Biological Chemistry. 244: 5828-35. PMID 4310825 |
0.578 |
|
1969 |
Perlman RL, De Crombrugghe B, Pastan I. Cyclic AMP regulates catabolite and transient repression in E. coli Nature. 223: 810-812. PMID 4307969 DOI: 10.1038/223810a0 |
0.532 |
|
1969 |
Levey GS, Roth J, Pastan I. Effect of propranolol and phentolamine on canine and bovine responses to TSH Endocrinology. 84: 1009-1015. PMID 4304995 DOI: 10.1210/ENDO-84-5-1009 |
0.325 |
|
1969 |
Roth J, Gorden P, Pastan I. "Big insulin": a new component of plasma insulin detected by immunoassay. Proceedings of the National Academy of Sciences of the United States of America. 61: 138-45. PMID 4301586 DOI: 10.1073/Pnas.61.1.138 |
0.348 |
|
1967 |
Taunton OD, Roth J, Pastan I. ACTH stimulation of adenyl cyclase in adrenal homogenates. Biochemical and Biophysical Research Communications. 29: 1-7. PMID 4293391 DOI: 10.1016/0006-291X(67)90531-1 |
0.347 |
|
1966 |
Tsai L, Pastan I, Stadtman ER. Nicotinic acid metabolism. II. The isolation and characterization of intermediates in the fermentation of nicotinic acid. The Journal of Biological Chemistry. 241: 1807-13. PMID 5945854 |
0.431 |
|
1966 |
Jakoby WB, Labaw L, Edelhoch H, Pastan I, Rall JE. Thyroglobulin: evidence for crystallization and association. Science (New York, N.Y.). 153: 1671-2. PMID 5917084 DOI: 10.1126/Science.153.3744.1671 |
0.52 |
|
1964 |
PASTAN I, TSAI L, STADTMAN ER. NICOTINIC ACID METABOLISM. I. DISTRIBUTION OF ISOTOPE IN FERMENTATION PRODUCTS OF LABELLED NICOTINIC ACID. The Journal of Biological Chemistry. 239: 902-6. PMID 14157025 |
0.431 |
|
Show low-probability matches. |